Article
Elastin expression in a newly developed full-thickness skin equivalent.
Phenion GmbH & Co. KG, Düsseldorf, Germany.
Skin pharmacology and physiology (impact factor:
2.92).
02/2007;
20(2):85-95.
DOI:10.1159/000097655
pp.85-95
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: Skin replacement in burn wounds.
The Journal of trauma 02/2010; 68(2):490-501. · 2.48 Impact Factor -
Article: Test systems for the determination of glucocorticoid receptor ligand induced skin atrophy.
[show abstract] [hide abstract]
ABSTRACT: Topical glucocorticoids are highly anti-inflammatory effective but limited by their side effect potential, with skin atrophy being the most prominent one. Thus, determining the atrophogenic potential of novel compounds targeting the glucocorticoid receptor is important. Significant progress in the understanding of glucocorticoid receptor mediated molecular action has been made providing the basis for novel glucocorticoid receptor ligands with a potentially superior effect/side effect profile. Such compounds, however, need to be tested. The present gold standard for the reliable prediction of glucocorticoid induced skin atrophy are still in vivo models, however, in vitro models may replace them to some extent in the future. Indeed, advances in technologies to determine the atrophogenic potential of compounds in vitro has been made recently and promising novel test models like the human full thickness skin models are emerging. Their full predictive value, however, needs to be further evaluated. Currently, a screening approach starting with a combination of several in vitro test systems followed by subsequent testing of the most promising compounds in rodent models is recommended prior entering clinical studies with selected development compounds.Dermato-endocrinology. 01/2011; 3(3):175-9.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
5-week cultivation period
age-dependent decrease
culture time
day 7
dermal elastic fibres
different lengths
differentiated epidermis
distribution patterns
elastic fibres
elastic system
elastin first
Elastin mRNA expression
extracellular matrix proteins
level comparable
pharmaceutical compounds
physiological property favours
promising animal-free approach
skin elasticity
stratum corneum
vivo-like elastic system